Literature DB >> 21059575

The relationship of chemotherapy-induced nausea to the frequency of pericardium 6 digital acupressure.

Jiyeon Lee1, Suzanne Dibble, Marylin Dodd, Donald Abrams, Beverly Burns.   

Abstract

PURPOSE/
OBJECTIVES: To explain the relationship between the intensity of chemotherapy-induced nausea (CIN) and the frequency of pericardium 6 (P6) digital acupressure.
DESIGN: Secondary data analysis of a multicenter, longitudinal, randomized, clinical trial.
SETTING: Nine community clinical oncology programs and six independent sites in the United States. SAMPLE: 53 patients with breast cancer who received moderate to highly emetogenic chemotherapy and applied P6 digital acupressure in addition to antiemetics to control CIN.
METHODS: A daily log measuring nausea intensity and the frequency of acupressure for 11 days after the administration of chemotherapy. Hierarchical generalized linear modeling procedure (multilevel negative binomial regression) was used for analyzing the data. MAIN RESEARCH VARIABLES: Nausea intensity and acupressure frequency.
FINDINGS: Participants used acupressure an average of two times per day (SD = 1.84, range 0-10). Women who used acupressure more frequently after the peak of nausea (on day 4) were predicted to have a 0.97-point higher nausea intensity in the acute phase than women who used acupressure less frequently, controlling for the effects of other variables in the model (incidence rate ratio = 1.52, p < 0.01).
CONCLUSIONS: Patients with breast cancer whose nausea intensity started higher from the acute phase continued to experience higher symptom intensity during the 11 days after chemotherapy administration and required more frequent acupressure even after the peak of nausea. IMPLICATIONS FOR NURSING: Careful assessment and management of acute CIN with continuous monitoring and care of CIN in the delayed phase are important nursing issues in caring for patients receiving chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059575     DOI: 10.1188/10.ONF.E419-E425

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  4 in total

1.  Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients.

Authors:  Sun Young Rha; Yeonhee Park; Su Kyung Song; Chung Eun Lee; Jiyeon Lee
Journal:  Support Care Cancer       Date:  2016-03-16       Impact factor: 3.603

2.  The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and vomiting.

Authors:  Aslı Genç; Gulbeyaz Can; Adnan Aydiner
Journal:  Support Care Cancer       Date:  2012-06-09       Impact factor: 3.603

Review 3.  Nausea and Vomiting Not Related to Cancer Therapy: Intractable Problem or Clinical Challenge?

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2020-07-01

Review 4.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.